Medtronic plc is a leading global medical device company that develops and manufactures innovative healthcare technologies and therapies. Its core portfolios encompass **Cardiovascular**, including ca... Medtronic plc is a leading global medical device company that develops and manufactures innovative healthcare technologies and therapies. Its core portfolios encompass **Cardiovascular**, including cardiac rhythm management, ablation solutions, structural heart, aortic, coronary, peripheral vascular, and mechanical circulatory support; **Diabetes**, offering insulin delivery systems and continuous glucose monitoring for type 1 and type 2 patients; **Medical Surgical**, featuring endoscopy, acute care and monitoring, ear, nose, and throat products; and **Restorative Therapies**, covering neuromodulation for chronic pain and movement disorders, cranial and spinal technologies, neurovascular interventions, and pelvic health solutions. Medtronic plc delivers devices such as implantable pacemakers, neurostimulation systems, remote monitoring software, and robotic-assisted surgical tools, addressing over 70 health conditions worldwide. With legal headquarters in Dublin, Ireland, and operational headquarters in Minneapolis, Minnesota since its 2015 rebase, the company operates across more than 150 countries, focusing on patient-centered solutions in high-growth medical sectors.
Financial Fundamentals data not yet covered for Medtronic
We have not yet reviewed Medtronic's disclosures for Financial Fundamentals data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.